[go: up one dir, main page]

YU24000A - Polimorfi dofetilida - Google Patents

Polimorfi dofetilida

Info

Publication number
YU24000A
YU24000A YU24000A YU24000A YU24000A YU 24000 A YU24000 A YU 24000A YU 24000 A YU24000 A YU 24000A YU 24000 A YU24000 A YU 24000A YU 24000 A YU24000 A YU 24000A
Authority
YU
Yugoslavia
Prior art keywords
polymorphs
dofetilide polymorphs
dofetilide
processes
preparation
Prior art date
Application number
YU24000A
Other languages
English (en)
Inventor
Lan Colin Aookeby
Trevor Jack Newbury
Gary Nichols
Original Assignee
Pfizer Research And Development Company N.V./S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU24000(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Research And Development Company N.V./S.A. filed Critical Pfizer Research And Development Company N.V./S.A.
Publication of YU24000A publication Critical patent/YU24000A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Pronalazak se odnosi na uglavnom čiste dofetilidne polimorfe P 162, P 162a i P 143 i na postupak za dobivanje preparata koji sadrže i koriste takve polimorfe.[The invention relates to the substantially pure dofetilide polymorphs P162, P162a and P143, and to processes for the preparation of, compositions containing and to the uses of, such polymorphs.
YU24000A 1997-10-27 1998-10-09 Polimorfi dofetilida YU24000A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs

Publications (1)

Publication Number Publication Date
YU24000A true YU24000A (sh) 2003-02-28

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
YU24000A YU24000A (sh) 1997-10-27 1998-10-09 Polimorfi dofetilida

Country Status (46)

Country Link
US (1) US6124363A (sh)
EP (1) EP1027329B1 (sh)
JP (1) JP3569495B2 (sh)
KR (1) KR100366167B1 (sh)
CN (1) CN1146537C (sh)
AP (1) AP906A (sh)
AR (1) AR015193A1 (sh)
AT (1) ATE232199T1 (sh)
AU (1) AU737668B2 (sh)
BG (1) BG64125B1 (sh)
BR (1) BR9813308A (sh)
CA (1) CA2307121C (sh)
CO (1) CO4970768A1 (sh)
DE (1) DE69811256T2 (sh)
DK (1) DK1027329T3 (sh)
DZ (1) DZ2632A1 (sh)
EA (1) EA002656B1 (sh)
ES (1) ES2190620T3 (sh)
GB (1) GB9722662D0 (sh)
GT (1) GT199800165A (sh)
HN (1) HN1998000165A (sh)
HR (1) HRP20000247B1 (sh)
HU (1) HUP0004735A3 (sh)
ID (1) ID24658A (sh)
IL (1) IL135435A0 (sh)
IS (1) IS2179B (sh)
MA (1) MA24683A1 (sh)
MY (1) MY123352A (sh)
NO (1) NO325630B1 (sh)
NZ (1) NZ503785A (sh)
OA (1) OA11350A (sh)
PA (1) PA8462001A1 (sh)
PE (1) PE122199A1 (sh)
PL (1) PL197379B1 (sh)
PT (1) PT1027329E (sh)
SA (1) SA98190834B1 (sh)
SI (1) SI1027329T1 (sh)
SK (1) SK5862000A3 (sh)
TN (1) TNSN98193A1 (sh)
TR (1) TR200001135T2 (sh)
TW (1) TW449589B (sh)
UA (1) UA67755C2 (sh)
UY (2) UY25222A1 (sh)
WO (1) WO1999021829A1 (sh)
YU (1) YU24000A (sh)
ZA (1) ZA989719B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ307826B6 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
IS2179B (is) 2006-12-15
US6124363A (en) 2000-09-26
HRP20000247A2 (en) 2000-10-31
DZ2632A1 (fr) 2003-03-08
TNSN98193A1 (fr) 2005-03-15
EA002656B1 (ru) 2002-08-29
CN1278246A (zh) 2000-12-27
AP9801371A0 (en) 1998-12-31
PA8462001A1 (es) 2000-05-24
GB9722662D0 (en) 1997-12-24
UY25222A1 (es) 2000-12-29
GT199800165A (es) 2000-04-19
PL340805A1 (en) 2001-02-26
NO20002191L (no) 2000-04-27
AU2151299A (en) 1999-05-17
BR9813308A (pt) 2000-08-22
AR015193A1 (es) 2001-04-18
SI1027329T1 (en) 2003-04-30
WO1999021829A1 (en) 1999-05-06
CN1146537C (zh) 2004-04-21
AU737668B2 (en) 2001-08-30
SA98190834B1 (ar) 2006-08-21
AP906A (en) 2000-11-30
KR20010031439A (ko) 2001-04-16
DE69811256T2 (de) 2003-09-18
PT1027329E (pt) 2003-04-30
TW449589B (en) 2001-08-11
CO4970768A1 (es) 2000-11-07
EP1027329B1 (en) 2003-02-05
SK5862000A3 (en) 2001-10-08
EA200000365A1 (ru) 2000-12-25
PE122199A1 (es) 1999-12-02
IS5426A (is) 2000-03-31
UA67755C2 (uk) 2004-07-15
DE69811256D1 (de) 2003-03-13
BG104373A (en) 2000-12-29
CA2307121A1 (en) 1999-05-06
CA2307121C (en) 2006-12-05
ID24658A (id) 2000-07-27
HRP20000247B1 (en) 2002-08-31
EP1027329A1 (en) 2000-08-16
ZA989719B (en) 2000-04-26
NO325630B1 (no) 2008-06-30
IL135435A0 (en) 2001-05-20
TR200001135T2 (tr) 2000-09-21
DK1027329T3 (da) 2003-02-24
OA11350A (en) 2003-12-17
JP3569495B2 (ja) 2004-09-22
HN1998000165A (es) 1999-02-09
MY123352A (en) 2006-05-31
HUP0004735A3 (en) 2001-12-28
JP2001521023A (ja) 2001-11-06
ES2190620T3 (es) 2003-08-01
UY25341A1 (es) 1999-09-27
PL197379B1 (pl) 2008-03-31
NZ503785A (en) 2004-11-26
KR100366167B1 (ko) 2003-01-09
NO20002191D0 (no) 2000-04-27
HK1033933A1 (en) 2001-10-05
HUP0004735A2 (hu) 2001-10-28
BG64125B1 (bg) 2004-01-30
MA24683A1 (fr) 1999-07-01
ATE232199T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
AU4815197A (en) Tetraphosphonate bicyclic trisanhydrides
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
BG102172A (en) New stable medicamentous compositions for the preparation of propellant-free aerosols
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
MY113806A (en) Antiparasitic marcfortines and paraherquamides
BG103485A (en) Ketobanzamides as calpain inhibitors
ZA9710098B (en) Halogenopyrimidines.
NZ503308A (en) Alpha-ketoamide multicatalytic protease inhibitors
BG103548A (en) Vitronectine receptor antagonists
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
BG103914A (en) Maintained separation of delayed gels
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
YU2500A (sh) Alatrofloksacin parenteralni preparati
YU24000A (sh) Polimorfi dofetilida
AP9400632A0 (en) Ether derivatives.
BG103649A (en) Method for the preparation of eprosartan
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
BG103650A (en) Method for the preparation of eprosartan
IL128186A0 (en) Intermediates for the preparation of 2-imidazoline-5-ones
IL138638A0 (en) Processes for preparing intermediates
IL133782A0 (en) Novel stereoselective processes for the preparation of gabapentin analogues
MX9602767A (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina.
TW282449B (sh)
ZA9711432B (en) Compositions for the preparation of leather.